MECP2 and Huntington disease: Huntington’s disease (HD) studies found that MeCP2 binds and inhibits the long isoform of nuclear enriched abundant transcript 1 (Neat1L) lncRNA in various neuronal and brain tissue types (Cheng et al., 2018).